Chemical Compound

(2R)-2-(((1R,3S,4S)-3-((4-(2-ethyl-5-(phenylmethyl)pyrazol-3-yl)piperidin-1-yl)methyl)-4-(3-fluorophenyl)cyclopentyl)-methylamino)-3-methylbutanoic acid

CAS Registry Number 313994-79-5
(2R)-2-(((1R,3S,4S)-3-((4-(2-ethyl-5-(phenylmethyl)pyrazol-3-yl)piperidin-1-yl)methyl)-4-(3-fluorophenyl)cyclopentyl)-methylamino)-3-methylbutanoic acid 结构式
Primary record

(2R)-2-(((1R,3S,4S)-3-((4-(2-ethyl-5-(phenylmethyl)pyrazol-3-yl)piperidin-1-yl)methyl)-4-(3-fluorophenyl)cyclopentyl)-methylamino)-3-methylbutanoic acid

库存
3,746 克
纯度
98.2 %
CAS
313994-79-5

化合物标识与属性

CAS
313994-79-5
PubChem CID
5481119
SMILES
CCN1C(=CC(=N1)CC2=CC=CC=C2)C3CCN(CC3)C[C@H]4C[C@@H](C[C@@H]4C5=CC(=CC=C5)F)N(C)[C@H](C(C)C)C(=O)O
Canonical SMILES
CCn1nc(Cc2ccccc2)cc1C1CCN(C[C@H]2C[C@H](N(C)[C@@H](C(=O)O)C(C)C)C[C@@H]2c2cccc(F)c2)CC1

名称与同义词

  • MRK-1
  • CMPD167
  • MRK1
  • RefChem:926178
  • D06TQD
  • AC1NUK70
  • CMPD 167
  • CMPD-167
  • DTXSID0047327
  • CMPD-167 (HIV infection)
  • MK-578
  • GTPL3651
  • orb1942068
  • CHEMBL3182547
  • DTXCID8027327
  • SCHEMBL29350723
  • MRK-167
  • 313994-79-5
  • Tox21_300223
  • CMPD-167 (HIV infection), IPM
  • L167
  • CCR5 inhibitor (HIV infection), IPM
  • CID5481119
  • NCGC00247944-01
  • NCGC00254081-01
  • DA-72297
  • CCR5 inhibitor (vaginal formulation), IPM
  • HY-124848
  • CAS-313994-79-5
  • CS-0088656
  • L-167
  • J2.150.702D
  • (2R)-2-[[(1R,3S,4S)-3-[[4-(5-benzyl-2-ethylpyrazol-3-yl)piperidin-1-yl]methyl]-4-(3-fluorophenyl)cyclopentyl]-methylamino]-3-methylbutanoic acid
  • Q27087736
  • N-((1R,3S,4S)-3-((4-(3-Benzyl-1-ethyl-1H-pyrazol-5-yl)piperidin-1-yl)methyl)-4-(3-fluorophenyl)cyclopentyl)-N-methyl-D-valine
  • CMPD-167 (HIV infection), International Partnership for Microbiocides
  • D-Valine, N-[(1R,3S,4S)-3-[[4-[1-ethyl-3-(phenylmethyl)-1H-pyrazol-5-yl]-1-piperidinyl]methyl]-4-(3-fluorophenyl)cyclopentyl]-N-methyl-
  • (2R)-2-(((1R,3S,4S)-3-((4-(2-ethyl-5-(phenylmethyl)pyrazol-3-yl)piperidin-1-yl)methyl)-4-(3-fluorophenyl)cyclopentyl)-methylamino)-3-methylbutanoic acid
  • (2R)-2-[[(1R,3S,4S)-3-[[4-(5-benzyl-2-ethyl-pyrazol-3-yl)-1-piperidyl]methyl]-4-(3-fluorophenyl)cyclopentyl]-methyl-amino]-3-methyl-butanoic acid
  • (2R)-2-[[(1R,3S,4S)-3-[[4-[2-ethyl-5-(phenylmethyl)pyrazol-3-yl]piperidin-1-yl]methyl]-4-(3-fluorophenyl)cyclopentyl]-methylamino]-3-methylbutanoic acid
  • (2R)-2-{[(1R,3S,4S)-3-{[4-(3-benzyl-1-ethyl-1H-pyrazol-5-yl)piperidin-1-yl]methyl}-4-(3-fluorophenyl)cyclopentyl](methyl)amino}-3-methylbutanoic acid
  • N-[(1R,3S,4S)-3-[[4-(1-Ethyl-3-benzyl-1H-pyrazole-5-yl)-1-piperidinyl]methyl]-4-(3-fluorophenyl)cyclopentyl]-N-methyl-D-valine
  • N-[(1R,3S,4S)-3-{[4-(3-benzyl-1-ethyl-1H-pyrazol-5-yl)piperidin-1-yl]methyl}-4-(3-fluorophenyl)cyclopentyl]-N-methyl-D-valine